BUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US

Reuters01-06

BUZZ-Telehealth stocks rise as <a href="https://laohu8.com/S/NVO">Novo Nordisk</a> launches Wegovy pill in US

** Shares of telehealth companies GoodRx GDRX.O, WeightWatchers WW.O and LifeMD LFMD.O rise between 3% and 14%

** LifeMD up 13.9% at $3.98, GoodRx up 3.1% at $2.84 and WeightWatchers up 4.3% at $32.80

** Novo Nordisk NOVOb.CO says its once-daily Wegovy pill will be available through telehealth providers, including LifeMD, WeightWatchers, GoodRx, and its own NovoCare Pharmacy

** Novo is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 mg and 4 mg doses at $149 per month for self-paying patients

** In the last 12 months GDRX down 41.7%, LFMD down 31.1%

** As of last close, WW up 8.2% since Nasdaq debut in June

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601839740?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-06 02:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601839740","market":"fut","top_or_hot":-1,"title":"BUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Telehealth stocks rise as <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> launches Wegovy pill in US</title></head><body><p>** Shares of telehealth companies GoodRx <span>GDRX.O</span>, WeightWatchers <span>WW.O</span> and LifeMD <span>LFMD.O</span> rise between 3% and 14%    </p><p>** LifeMD up 13.9% at $3.98, GoodRx up 3.1% at $2.84 and WeightWatchers up 4.3% at $32.80  </p><p>** Novo Nordisk <span>NOVOb.CO</span> <span>says</span> its once-daily Wegovy pill will be available through telehealth providers, including LifeMD, WeightWatchers, GoodRx, and its own NovoCare Pharmacy  </p><p> ** Novo is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 mg and 4 mg doses at $149 per month for self-paying patients</p><p>** In the last 12 months GDRX down 41.7%, LFMD down 31.1%</p><p>** As of last close, WW up 8.2% since Nasdaq debut in June  </p><p>(Reporting by Sneha S K)</p><p>((Sneha.SK@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-06 02:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Telehealth stocks rise as <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> launches Wegovy pill in US</title></head><body><p>** Shares of telehealth companies GoodRx <span>GDRX.O</span>, WeightWatchers <span>WW.O</span> and LifeMD <span>LFMD.O</span> rise between 3% and 14%    </p><p>** LifeMD up 13.9% at $3.98, GoodRx up 3.1% at $2.84 and WeightWatchers up 4.3% at $32.80  </p><p>** Novo Nordisk <span>NOVOb.CO</span> <span>says</span> its once-daily Wegovy pill will be available through telehealth providers, including LifeMD, WeightWatchers, GoodRx, and its own NovoCare Pharmacy  </p><p> ** Novo is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 mg and 4 mg doses at $149 per month for self-paying patients</p><p>** In the last 12 months GDRX down 41.7%, LFMD down 31.1%</p><p>** As of last close, WW up 8.2% since Nasdaq debut in June  </p><p>(Reporting by Sneha S K)</p><p>((Sneha.SK@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFMD","symbol_name":"LifeMD Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nL4N3Y61AX:1","article_id":"2601839740","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601839740","pubTimestamp":1767638303,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US** Shares of telehealth companies GoodRx GDRX.O, WeightWatchers WW.O and LifeMD LFMD.O rise between 3% and 14%    ** LifeMD up 13.9% at $3.98, GoodRx up 3.1% at $2.84 and WeightWatchers up 4.3% at $32.80  ** Novo Nordisk NOVOb.CO says its once-daily Wegovy pill will be available through telehealth providers, including LifeMD, WeightWatchers, GoodRx, and its own NovoCare Pharmacy   ** Novo is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 mg and 4 mg doses at $149 per month for self-paying patients** In the last 12 months GDRX down 41.7%, LFMD down 31.1%** As of last close, WW up 8.2% since Nasdaq debut in June  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LFMD":"LifeMD Inc.","BK4167":"医疗保健技术","BK4192":"特殊消费者服务","GDRX":"GoodRx Holdings, Inc.","BK4183":"个人用品","WW":"WW International, Inc."},"translate_title":"随着诺和诺德在美国推出Wegovy药丸，远程医疗股上涨","themeId":"7cdb4d6fc59fdc15e0ae3987ae0b85e0","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFMD":0.9,"WW":0.9,"GDRX":0.9},"content_text":"BUZZ-Telehealth stocks rise as Novo Nordisk launches Wegovy pill in US** Shares of telehealth companies GoodRx GDRX.O, WeightWatchers WW.O and LifeMD LFMD.O rise between 3% and 14%    ** LifeMD up 13.9% at $3.98, GoodRx up 3.1% at $2.84 and WeightWatchers up 4.3% at $32.80  ** Novo Nordisk NOVOb.CO says its once-daily Wegovy pill will be available through telehealth providers, including LifeMD, WeightWatchers, GoodRx, and its own NovoCare Pharmacy   ** Novo is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 mg and 4 mg doses at $149 per month for self-paying patients** In the last 12 months GDRX down 41.7%, LFMD down 31.1%** As of last close, WW up 8.2% since Nasdaq debut in June  (Reporting by Sneha S K)((Sneha.SK@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601839740","isCrawlerRequest":true}